Replies to post #967 on Aethlon Medical Inc (AEMD)

[yielddude]

Sheff, excellent post, maybe sticky it at top?

[GWMAN]

In relation to Shef's post, if people go watch the Sept 30th Redchip conference presentation, note that there are accompanying slides that can be downloaded at the site (note these slides are different than the June 16th slides contained in Shef's post).

Shef, by the way, nice to have you here a bit:-) Thanks for contributing!

[jayree]

Sheff thanks for the call... I got in at .45 I very much appreciate what you do... thanks again.

[$heff]

AEMD (.515) is looking forward to presenting their data from India w/ Dr. Kher presenting. This data will allow the company to do clinical studies in the U.S. and will help faciliate potential partnerships w/ big pharma. The American Society of Nephrology meeting this Friday will be huge for AEMD. They will then be able to meet with the FDA to discuss their clinical results and get the stamp of approval to be used as an adjunct therapy to first-line therapy for HCV. Win-win situation for the company. $heff